Electroporation-facilitated delivery of plasmid DNA in skeletal muscle: Plasmid dependence of muscle damage and effect of poloxamer 188

Molecular Therapy

Volumn 4, Issue 5, 2001, Pages 407-415

  Hartikka, Jukka ^a   Sukhu, Loretta ^a   Buchner, Carol ^a   Hazard, Diane ^a   Bozoukova, Vesselina ^a   Margalith, Michal ^a   Nishioka, Walter K ^a   Wheeler, Carl J ^a   Manthorp, Marston ^a   Sawdey, Michael ^a  

^a VICAL INC   (United States)

Author keywords

Electroporation; Naked DNA; Pluronic F68; Poloxamer 188; Skeletal muscle

Indexed keywords

CREATINE KINASE; LUCIFERASE; PLASMID DNA; PLURACARE F68; POLOXAMER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DOSE RESPONSE; ELECTRODE; ELECTROPORATION; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; GENE TARGETING; GENE TRANSFER; MOUSE; MUSCLE INJURY; NONHUMAN; QUADRICEPS FEMORIS MUSCLE; REPORTER GENE; SKELETAL MUSCLE; TRANSGENE;

ANIMALIA; TRIXIS;

EID: 0035184531     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1006/mthe.2001.0483     Document Type: Article

References (43)

1. Direct gene transfer into mouse muscle in vivo
2. Plasmid DNA is superior to viral vectors for direct gene transfer into adult mouse skeletal muscle
3. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy
4. Cancer gene therapy using plasmid DNA: Safety evaluation in rodents and non-human primates
5. A gene therapy for cancer using intramuscular injection of plasmid DNA encoding interferon α
6. Heterologous protection against influenza by injection of DNA encoding a viral protein
7. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine
8. Left ventricular electromechanical mapping to assess efficacy of phVEGF(165) gene transfer for therapeutic angiogenesis in chronic myocardial ischemia
9. Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: Preliminary clinical results
10. Gene therapy by intramuscular injection of plasmid DNA: Studies on firefly luciferase gene expression in mice
11. An improved plasmid DNA expression vector for direct injection into skeletal muscle
12. Sodium phosphate enhances plasmid DNA expression in vivo
13. Gene transfer into muscle by electroporation in vivo
14. High-efficiency gene transfer into skeletal muscle mediated by electric pulses
15. Electropermeabilization of skeletal muscle enhances gene transfer in vivo
16. Efficient and regulated erythropoietin production by naked DNA injection and muscle electroporation
17. Erythropoietin secretion and physiological effect in mouse after intramuscular plasmid DNA electrotransfer
18. Continuous erythropoietin delivery by muscle-targeted gene transfer using in vivo electroporation
19. Gene electrotransfer results in a high-level transduction of rat skeletal muscle and corrects anemia of renal failure
20. Long-term production of erythropoetin after electroporation-mediated transfer of plasmid DNA into the muscles of normal and uremic rats
21. Electrochemotherapy, a new antitumor treatment. First clinical phase I- II trial
22. Antitumor electrochemotherapy: New advances in the clinical protocol
23. Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy
24. The 1995 Lindberg Award. Nonthermally mediated muscle injury and necrosis in electrical trauma
25. Transient and stable ionic permeabilization of isolated skeletal muscle cells after electrical shock
26. Kinetics of sealing for transient electropores in isolated mammalian skeletal muscle cells
27. In vivo electroporation of skeletal muscle: Threshold, efficacy and relation to electric field distribution
28. Importance of association between permeabilization and electrophoretic forces for intramuscular DNA electrotransfer
29. Muscle transfection by electroporation with high-voltage and short-pulse currents provides high-level and long-lasting gene expression
30. Serum creatine phosphokinase (CPK) activity in disorders of heart and skeletal muscle
31. Surfactant-induced sealing of electropermeabilized skeletal muscle membranes in vivo
32. Distribution of DNA vaccines determines their immunogenicity after intramuscular immunization in mice
33. Spatial-temporal patterns of gene expression in mouse skeletal muscle after injection of lacZ plasmid DNA
34. Inflammatory responses following direct injection of plasmid DNA into skeletal muscle
35. Direct immunologic activities of CpG DNA and implications for gene therapy
36. Rhabdomyolysis due to pulsed electric fields
37. A combination of poloxamers increases gene expression of plasmid DNA in skeletal muscle
38. Surfactant sealing of membranes permeabilized by ionizing radiation
39. Effectiveness of poloxamer 188 in arresting calcein leakage from thermally damaged isolated skeletal muscle cells
40. Physical basis for poloxamer interactions
41. Cancer gene therapy using plasmid DNA: Purification of DNA for human clinical trials